ArticleCurrent opinion in biomedical engineering2026
Stromal cell-mediated tuning of the extracellular matrix for immune tissue engineering.
Article in Current opinion in biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Advancing in vitro models of immune tissues is a major focus toward answering lingering questions about immunity and developing physiologically relevant drug testing platforms. The composition and structure of the extracellular matrix is an essential consideration in these models as these physical cues can modulate immune cell behavior and ability to mount an immune response. In immune tissues, stromal cells deposit and maintain the extracellular matrix, yet they are often overlooked in existing engineered models. Within, three major strategies for tuning the extracellular matrix in vitro for immune tissue engineering are explored: tunable hydrogel platforms, decellularized tissues, and in-situ deposition of matrix by stromal cells. Overall, the challenge of recapitulating in vivo microenvironments is vast, but the inclusion of stromal cells in the study of extracellular matrix-immune cell dynamics is a vital step forward.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.